NFKB1 and diffuse large B-cell lymphoma: The constitutive activation of nuclear factor κB (NF-κB) is one of the key signaling pathways involved in DLBCL growth and survival, particularly in the case of the activated B-cell-like (ABC) subtype [23,24].